Ana, 28 años: «Usé Papilocare como parte de mi tratamiento para el VPH y las verrugas genitales. No solo ayudó a reducir las verrugas, sino que también mejoró mi salud vaginal en general. Me siento mucho más cómoda y segura ahora que estoy usando este producto». Estudios científicos y respaldo médico

Papilocare® yra gelis, kuris sukuria sluoksnį ant gimdos kaklelio gleivinės ir sudaro apsauginį barjerą, kad būtų išvengta ŽPV integracijos pavojaus. Tokiu būdu nutrūksta ŽPV integracija, formuojasi nauji pažeidimai, taip pat padeda iš naujo epitelizuoti esamus pažeidimus. Tai taip pat skatina gimdos mikrobiotos atkūrimą. Kam skirta Papilocare®? Papilocare Gel Vaginal poate fi utilizat pentru a combate uscăciunea și disconfortul asociat mucoasei cervico-vaginale. Gelul hidratează și menține nivelul optim de umiditate, contribuind astfel la restabilirea confortului și sănătății vaginale. Women were randomized (1:1:1) into 3 treatment groups: scheme A, scheme B, or control (watchful waiting approach). Scheme A comprised using Papilocare once daily, preferably at bedtime, for 21 consecutive days followed by 7 days with no treatment throughout the first month, then an alternate-day therapy (except during the menstrual cycle) lasting up to 6 months. Scheme B was similar to scheme A except for the fact that the 21-day treatment/7-day rest period lasted for 3 months (instead of one) and that the alternate-day therapy lasted up to 3 months. Randomization was carried out using a centralized, computer-generated randomization list. Although sexual relations were not forbidden, the use of condoms was strongly recommended. The use of douches and vaginal deodorants was not allowed. Analyzed Variables O imbunatatire a procesului de vindecare atunci cand este utilizat ca si coadjuvant in tratamentul leziunilor intraepiteliale cauzate de HPV la nivelul mucoasei cervico-vaginale.

Papilocare 7 (7x5ml)

Obstetrics and Gynaecology Department, Hospital Quironsalud, Av. Imperio Argentina, 1, 29004 Málaga, Spain. Controlul si reepitelizarea zonei de transformare a colului uterin pentru a preveni riscul de aparitie a leziunilor (LSIL) cauzate de HPV. Laura, 32 años: «Después de ser diagnosticada con VPH y tener lesiones cervicales, mi médico me recomendó usar Papilocare. Después de un par de ciclos de tratamiento, las lesiones se redujeron significativamente y mi médico quedó impresionado con los resultados. Estoy muy agradecida por este producto y lo recomiendo a cualquiera que esté luchando con el VPH».

Veľmi podstatnú úlohu vúčinnej obrannej reakcii proti vírusu HPV zaisťuje celkové „ vaginálne zdravie“. Vaginálne ( pošvové ) zdravie, ktoré je významne určené osídlením pošvového kompartmentu normálnym mikrobiómom. Dysbióza vaginálneho mikrobiómu podmieňuje progresiu infekcie HPV smerom knádorovému bujneniu. Papilocare immunocaps from Procare Health is a food supplement that helps normalize the functioning of the immune system, formulated from bio-optimized ingredients capable of balancing the microbiota. Prevención de lesiones cervicales y vaginales: El uso regular de Papilocare ayuda a prevenir la aparición de lesiones relacionadas con el VPH en la zona cervical y vaginal. The purpose of the present study was to evaluate the efficacy of Papilocare in repairing cervical mucosa lesions in HPV-positive women with low-grade Pap smear alterations and consistent colposcopy observations. METHODS Study Design and Patients Obstetrics and Gynaecology Department, Hospital General Universitario, C. Pintor Baeza, 11, 03010 Alicante, Spain.

En un estudio clínico publicado en la revista «European Journal of Obstetrics & Gynecology and Reproductive Biology», se encontró que el uso de Papilocare durante 6 meses redujo significativamente la presencia de lesiones cervicales de alto grado en mujeres con VPH. Extract de Neem: actiune emolienta care favorizeaza procesul natural de vindecare cu ameliorarea simptomelor de roseata si mancarime. Persoanele cu sensibilitate crescută la oricare dintre ingredientele din Papilocare Gel Vaginal pot prezenta reacții alergice, cum ar fi mâncărime, erupții cutanate, umflături sau dificultăți de respirație. În astfel de cazuri, trebuie întreruptă imediat utilizarea gelului și trebuie solicitat sfatul medical. The results of our study have been replicated in several independent, observational, noncontrolled studies performed in Spanish public university hospitals. 35–37 The 6-month effectiveness of Papilocare was evaluated and confirmed in all of the studies (between 53% and 72.5% of cases achieved a negative cytology and/or HPV clearance/reduced viral load). An update of the study by Riera et al., 38 which included a watchful waiting control group, revealed a significantly higher percentage of responders in the group treated with Papilocare compared with the controls (80.0% vs 51.4%). Recent interim results from the observational, multicenter, prospective, single-cohort PAPILOBS study (#NTC04199260) revealed a notable effect of Papilocare at 6 months in repairing HPV-dependent low-grade cervical lesions and clearing HPV (66% and 63% of patients, respectively) under real-life conditions. 39 Data obtained in the present study in relation to the HPV clearance, especially in HR HPV patients, are consistent with real-world data obtained in other studies. 40 Moreover, in this trial, the degree of cervical re-epithelization was significantly higher with Papilocare compared with the control group. This beneficial effect on re-epithelization was also observed by Palacios et al. 15 in a pilot study performed with 21 asymptomatic non–HPV-infected women, in which women treated Papilocare achieved improved cervical re-epithelization (from 3.1 to 4.4 according to the same cervical epithelization scoring system used in the present study). Similarly, Gálvez et al. 16 reported a significant 20% improvement in cervical re-epithelialization in HPV-positive lesion-free women treated with Papilocare (3.8 vs 4.5) compared with baseline.

Changes in the cervical re-epithelization score (Likert scale) between baseline and the 3- and 6-month visits. Values are expressed as the mean together with the SD (between parentheses). *χ 2 test. Vaginal HealthB-glucan niosomes): благодарение на антиоксидантните си качества, поддържат структурата и естествените функции на кожата и лигавиците. Papilocare se presenta en forma de gel en un tubo con aplicador, lo que facilita su aplicación y dosificación. El aplicador está diseñado para garantizar una distribución uniforme del gel en la zona vaginal, maximizando su eficacia y minimizando el riesgo de irritación o molestias. El envase de Papilocare contiene suficiente gel para un ciclo completo de tratamiento, y las instrucciones detalladas de uso se incluyen en el prospecto que acompaña al producto. Beneficios de Papilocare Papilocare Gel Vaginal poate fi utilizat ca parte a tratamentului leziunilor intraepiteliale la nivelul mucoasei cervico-vaginale, grăbind procesul de vindecare și favorizând regenerarea țesuturilor afectate. sarcină, înainte de a utiliza Papilocare, este necesar să consultați un medic, iar aplicarea ar trebui Estos estudios, junto con el respaldo de ginecólogos y profesionales de la salud, confirman que Papilocare es una opción de tratamiento efectiva y segura para las mujeres afectadas por el VPH y sus complicaciones asociadas. ¿Dónde adquirir Papilocare?